Daiichi Sankyo, UCB Get Academic Partners | Chemical & Engineering News
Volume 92 Issue 15 | p. 15 | Concentrates
Issue Date: April 14, 2014

Daiichi Sankyo, UCB Get Academic Partners

Department: Business
Keywords: partnership, drug discovery, high throughput screening

Daiichi Sankyo and the University of California, San Francisco, have formed a drug discovery collaboration focused on neurodegenerative diseases. Daiichi Sankyo will provide its compound library to the UC San Francisco Institute for Neurodegenerative Diseases, and the partners will jointly perform high-throughput compound screening. Meanwhile, the Belgian drug company UCB has formed a research partnership with Weill Cornell Medical College. UCB will fund research programs in bone disorders, metabolic disease, and rare-genetic-variant analysis.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment